Annual Accounts Payable
$13.99 M
+$10.38 M+287.34%
31 December 2023
Summary:
Zevra Therapeutics annual accounts payable is currently $13.99 million, with the most recent change of +$10.38 million (+287.34%) on 31 December 2023. During the last 3 years, it has risen by +$12.81 million (+1091.40%). ZVRA annual accounts payable is now at all-time high.ZVRA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
N/A
30 September 2024
Summary:
Zevra Therapeutics quarterly accounts payable is not available.ZVRA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVRA Accounts Payable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +287.3% | - |
3 y3 years | +1091.4% | - |
5 y5 years | +276.5% | - |
ZVRA Accounts Payable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +2610.7% | ||
5 y | 5 years | at high | +2610.7% | ||
alltime | all time | at high | +3522.6% |
Zevra Therapeutics Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $13.99 M(+287.3%) | $13.99 M(+60.6%) |
June 2023 | - | $8.71 M(+141.2%) |
Dec 2022 | $3.61 M(+599.8%) | $3.61 M(+599.8%) |
Dec 2021 | $516.00 K(-56.0%) | - |
Dec 2021 | - | $516.00 K(-56.0%) |
Dec 2020 | $1.17 M(+3.0%) | $1.17 M(+3.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2019 | $1.14 M(-69.3%) | $1.14 M(-69.3%) |
Dec 2018 | $3.71 M(+70.6%) | $3.71 M(+70.6%) |
Dec 2017 | $2.18 M(+364.2%) | $2.18 M(+364.2%) |
Dec 2016 | $469.00 K(-62.5%) | $469.00 K(-62.5%) |
Dec 2015 | $1.25 M(-20.9%) | $1.25 M(-20.9%) |
Dec 2014 | $1.58 M(+309.7%) | $1.58 M |
Dec 2013 | $386.10 K | - |
FAQ
- What is Zevra Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Zevra Therapeutics?
- What is Zevra Therapeutics annual accounts payable year-on-year change?
- What is the all time high quarterly accounts payable for Zevra Therapeutics?
What is Zevra Therapeutics annual accounts payable?
The current annual accounts payable of ZVRA is $13.99 M
What is the all time high annual accounts payable for Zevra Therapeutics?
Zevra Therapeutics all-time high annual accounts payable is $13.99 M
What is Zevra Therapeutics annual accounts payable year-on-year change?
Over the past year, ZVRA annual accounts payable has changed by +$10.38 M (+287.34%)
What is the all time high quarterly accounts payable for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly accounts payable is $13.99 M